NCT00443963View on ClinicalTrials.gov

Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Dyspepsia

Interventions

DRUG

Esomeprazole Magnesium

PPI compared to H2RA

Trial Locations (1)

20010

Washington Hospital Center, Washington D.C.

Sponsors

Lead Sponsor

Medstar Health Research Institute

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Medstar Health Research Institute

OTHER